Search filters

List of works by Joan Josep Castellano

Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer

scientific article published on 28 February 2019

Exosomal microRNAs isolated from plasma of mesenteric veins linked to liver metastases in resected patients with colon cancer

scientific article

Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery

scientific article published on 21 February 2019

Extracellular Vesicle lincRNA-p21 Expression in Tumor-Draining Pulmonary Vein Defines Prognosis in NSCLC and Modulates Endothelial Cell Behavior

scientific article published on 20 March 2020

Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.

scientific article published on 7 May 2016

LincRNA-p21 Impacts Prognosis in Resected Non-Small Cell Lung Cancer Patients through Angiogenesis Regulation.

scientific article published on 2 August 2016

LincRNA-p21 Levels Relates to Survival and Post-Operative Radiotherapy Benefit in Rectal Cancer Patients

scientific article published on 31 August 2020

NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer

scientific article published on 13 December 2017

PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma

scientific article published on 14 June 2016

Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients

scientific article published on 23 August 2018

Proteomic Analysis of Liquid Biopsy from Tumor-Draining Vein Indicates that High Expression of Exosomal ECM1 Is Associated with Relapse in Stage I-III Colon Cancer

scientific article published on 13 April 2018

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.

scientific article

miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1.

scientific article

Paulina is supported by:

About Paulina

Help